Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-26-015320
Filing Date
2026-04-06
Accepted
2026-04-06 16:37:38
Documents
16
Period of Report
2026-04-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm   iXBRL DEF 14A 497017
2 GRAPHIC proxy_001.jpg GRAPHIC 633478
3 GRAPHIC proxy_002.jpg GRAPHIC 227405
  Complete submission text file 0001493152-26-015320.txt   2870391

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE immx-20251231.xsd EX-101.SCH 4006
5 XBRL DEFINITION FILE immx-20251231_def.xml EX-101.DEF 4220
6 XBRL LABEL FILE immx-20251231_lab.xml EX-101.LAB 54961
7 XBRL PRESENTATION FILE immx-20251231_pre.xml EX-101.PRE 43766
19 EXTRACTED XBRL INSTANCE DOCUMENT formdef14a_htm.xml XML 24671
Mailing Address 10573 W. PICO BLVD. #58 LOS ANGELES CA 90064
Business Address 11400 WEST OLYMPIC BLVD. SUITE 200 LOS ANGELES CA 90064 (888) 958-1084
Immix Biopharma, Inc. (Filer) CIK: 0001873835 (see all company filings)

EIN.: 454869378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41159 | Film No.: 26841753
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)